Apontis Pharma AG (XTER:APPH) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Change In Payables And Accrued Expense?

Apontis Pharma AG's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was €0.00 Mil. It means Apontis Pharma AG's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

Apontis Pharma AG's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was €0.00 Mil. It means Apontis Pharma AG's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Apontis Pharma AG Change In Payables And Accrued Expense Historical Data

The historical data trend for Apontis Pharma AG's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Change In Payables And Accrued Expense Chart

Apontis Pharma AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Apontis Pharma AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial							-	-	-	-	-

Apontis Pharma AG Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Apontis Pharma AG Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Rolf-Schwarz-Schutte-Platz 1, Monheim, BY, DEU, 40789

Website

https://www.apontis-pharma.de

Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.

Executives

Bruno Wohlschlegel	Board of Directors
Thomas Milz	Board of Directors
Thomas Zimmermann	Chief Financial Officer
Karlheinz Gast	Board of Directors

Apontis Pharma AG Headlines

No Headlines